Nautilus Biotechnology, Inc. (NAUT) vs NRx Pharmaceuticals, Inc. (NRXP)
Nautilus Biotechnology, Inc. and NRx Pharmaceuticals, Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and NRx Pharmaceuticals, Inc. are of similar size ($131.2M and $126.1M). Nautilus Biotechnology, Inc. has the higher net margin (0.00% vs −691.8%) and the lower return on invested capital (−83.3% vs 0.00%). Across the 13 metrics below, NRx Pharmaceuticals, Inc. leads on 8 and Nautilus Biotechnology, Inc. on 5.
Valuation
Profitability
| Metric | NAUT | NRXP | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 46.64% | 65.16% |
| Operating margin | 0.00% | (586.15%) | 0.00% |
| Net margin | 0.00% | (691.78%) | 0.00% |
| Free cash flow margin | 0.00% | (609.02%) | 0.00% |
| Return on equity | (36.21%) | 131.22% | (57.72%) |
| Return on assets | (30.00%) | (120.41%) | (49.22%) |
| Return on invested capital | (83.32%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack